We subsequently demonstrated robust anti-tumour functions of CD3-CD56+ NK cells (S1 Fig) when challenged with each tumour cell line, quantified by CD107a expression on the NK cell surface and intracellular IFNγ production (Fig 1C and 1D). This evidence concerns the gene LAMP1 and neoplasm.